Evidence map›Paper›PMID 41017822›Full record

ArticleComputational and structural biotechnology journal2025

OncoProExp: An interactive shiny web application for comprehensive cancer proteomics and phosphoproteomics analysis.

Edris Sharif Rahmani, Prakash Lingasamy, Soheila Khojand, Ankita Lawarde, Sergio Vela Moreno, Andres Salumets, Vijayachitra Modhukur

Erratum issuedAbstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Edris Sharif RahmaniCelvia CC AS, Tartu 50411, Estonia.
Prakash LingasamyCelvia CC AS, Tartu 50411, Estonia.
Soheila KhojandCelvia CC AS, Tartu 50411, Estonia.
Ankita LawardeCelvia CC AS, Tartu 50411, Estonia.
Sergio Vela MorenoCelvia CC AS, Tartu 50411, Estonia.
Andres SalumetsCelvia CC AS, Tartu 50411, Estonia.
Vijayachitra ModhukurCelvia CC AS, Tartu 50411, Estonia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer research has been revolutionized by mass spectrometry (MS)-based proteomics, enabling large-scale profiling of proteins and post-translational modifications (PTMs) to identify critical alterations in cancer signaling pathways. However, the lack of comprehensive, user-friendly platforms for integrative analysis limits efficient data exploration, biomarker discovery, and translational insights. To address this, we developed OncoProExp, a Shiny-based interactive web application for in-depth cancer proteomic and phosphoproteomic analyses. OncoProExp offers robust workflows for data preprocessing, interactive visualizations (PCA, hierarchical clustering, heatmaps, gene set enrichment analysis (GSEA)), and functional annotation of gene expression data. Differential expression analysis facilitates biomarker and therapeutic target discovery, while survival analysis identifies proteins whose expression stratifies overall survival, and pan-cancer exploration integrates clinical proteomic and phosphoproteomic datasets. OncoProExp also incorporates state-of-the-art predictive modeling, including Support Vector Machines (SVMs), Random Forests, and Artificial Neural Networks (ANNs) to classify cancer types from proteomic and phosphoproteomic profiles. These models were enhanced by SHapley Additive exPlanations (SHAP) for interpretability. To enhance its translational utility, OncoProExp supports user-uploaded data, protein-protein interactions, pathway enrichment, drug relevance evaluation, and clinical annotation analysis. OncoProExp is deployable via Docker containers, ensuring flexible and scalable integration into individual servers. Its utility has been demonstrated using Clinical Proteomic Tumor Analysis Consortium (CPTAC) datasets. OncoProExp is freely accessible at https://oncopro.cs.ut.ee/ without login requirements, offering a comprehensive resource for translational cancer research.

Indexed as

Biomarker discoveryCancer proteomicsMachine learningPhosphoproteomicsPrecision oncologyShiny web application

Identifiers

PMID41017822
PMCPMC12465049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.